Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells
NCT00630721
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Interventions
OTHER:
IFNbeta-1b
Sponsor
University of North Carolina, Chapel Hill